Allakos Inc. (ALLK) Social Stream
Allakos Inc (ALLK) Price Targets From Analysts
Use the tables below to see what analysts covering Allakos Inc think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 37 weeks, ALLK's average price target has gone down $136.38.
ALLK reports an average of 163.73% for its upside potential over the past 48 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
ALLK Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
ALLK's average broker recommendation rating improved by 0 over the prior 59 days.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ALLK as an investment opportunity.
- In terms of how Allakos Inc fares relative to all US stocks, note that its variance in analysts' estimates is lower than -961.56% of that group.
- To contextualize these metrics, consider that out of all US stocks, Allakos Inc's upside potential (average analyst target price relative to current price) is greater than 1017.01% of them.
- In terms of how Allakos Inc fares relative to stocks in the mid market cap category, note that its average analyst price target is higher than 543.06% of that group.
- In the context of Pharmaceutical Products stocks, Allakos Inc's number of analysts covering the stock is higher than 875.66% of them.
Is ALLK a Buy, Hold or Sell? See the POWR Ratings now!